Literature DB >> 3777914

Aztreonam concentrations in human tissues obtained during thoracic and gynecologic surgery.

T R Beam, R P Galask, L T Friedhoff, T B Platt, M A Leitz.   

Abstract

The concentrations of aztreonam in human tissues obtained during surgery were measured after a single 2-g intravenous dose. The average concentration in the skeletal muscle, atrial appendage, lung, sternum, pericardial fluid, endometrium, myometrium, fallopian tube, and ovary varied from 3 to 33 micrograms/g (or microgram/ml). These concentrations significantly exceed the MIC for 90% of strains for most members of the family Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777914      PMCID: PMC180589          DOI: 10.1128/AAC.30.3.505

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Aztreonam concentrations in human prostatic tissue.

Authors:  P O Madsen; R Dhruv; L T Friedhoff
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

2.  Biliary excretion of aztreonam in patients with biliary tract disease.

Authors:  O V Martinez; J U Levi; R G Devlin
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

3.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

4.  Pharmacokinetics and extravascular penetration of aztreonam in patients with abdominal sepsis.

Authors:  N E Winslade; I L Smith; G W Simons; D J Swanson; A Vigano; P B Wels; J J Schentag
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec

5.  Penetration of cefotaxime into heart valves, subcutaneous and muscle tissue of patients undergoing open-heart surgery.

Authors:  H M Just; M Bassler; U Frank; G Spillner; V Schlosser; F Daschner
Journal:  J Antimicrob Chemother       Date:  1984-10       Impact factor: 5.790

6.  Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.

Authors:  F D Daschner; E E Petersen; U Frank; D Hornig
Journal:  Am J Med       Date:  1984-12-21       Impact factor: 4.965

7.  Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.

Authors:  J S Gerig; N D Bolton; E A Swabb; W M Scheld; W K Bolton
Journal:  Kidney Int       Date:  1984-09       Impact factor: 10.612

8.  Pharmacokinetic study of moxalactam in patients undergoing gynecologic operations.

Authors:  M A Rettenmaier; R D Miller; M L Berman; P J DiSaia
Journal:  Am J Obstet Gynecol       Date:  1984-12-01       Impact factor: 8.661

9.  High-pressure liquid chromatographic analysis of aztreonam in sera and urine.

Authors:  F G Pilkiewicz; B J Remsburg; S M Fisher; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

10.  Pharmacokinetics and tissue penetration of azthreonam.

Authors:  R Wise; A Dyas; A Hegarty; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

View more
  4 in total

1.  Filamentous bacteriophages are associated with chronic Pseudomonas lung infections and antibiotic resistance in cystic fibrosis.

Authors:  Elizabeth B Burgener; Johanna M Sweere; Michelle S Bach; Patrick R Secor; Naomi Haddock; Laura K Jennings; Rasmus L Marvig; Helle Krogh Johansen; Elio Rossi; Xiou Cao; Lu Tian; Laurence Nedelec; Søren Molin; Paul L Bollyky; Carlos E Milla
Journal:  Sci Transl Med       Date:  2019-04-17       Impact factor: 17.956

Review 2.  Clinical pharmacokinetics of aztreonam. An update.

Authors:  H Mattie
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of aztreonam.

Authors:  H Mattie
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

4.  Evaluation of a New Culture-Based AtbFinder Test-System Employing a Novel Nutrient Medium for the Selection of Optimal Antibiotics for Critically Ill Patients with Polymicrobial Infections within 4 h.

Authors:  George Tetz; Victor Tetz
Journal:  Microorganisms       Date:  2021-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.